---
title: "Eli Lilly & Co. Stock Underperforms Thursday When Compared To Competitors"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/278939208.md"
description: "Eli Lilly & Co. (LLY) shares fell 2.26% to $977.25 on Thursday, marking the third consecutive day of losses. The stock is now 13.82% below its 52-week high of $1,133.95. In comparison, competitors like Johnson & Johnson (JNJ), Pfizer Inc. (PFE), and AbbVie Inc. (ABBV) also experienced declines, but to a lesser extent. The overall market was down, with the S&P 500 Index falling 1.52% and the Dow Jones Industrial Average down 1.56%. Trading volume was below average at 2.3 million shares."
datetime: "2026-03-12T20:32:00.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/278939208.md)
  - [en](https://longbridge.com/en/news/278939208.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/278939208.md)
---

# Eli Lilly & Co. Stock Underperforms Thursday When Compared To Competitors

This article was automatically generated by MarketWatch using technology from Automated Insights.

Shares of Eli Lilly & Co. (LLY) slipped 2.26% to $977.25 Thursday, on what proved to be an all-around poor trading session for the stock market, with the S&P 500 Index falling 1.52% to 6,672.62 and Dow Jones Industrial Average falling 1.56% to 46,677.85.

This was the stock's third consecutive day of losses.

Eli Lilly & Co. closed 13.82% below its 52-week high of $1,133.95, which the company achieved on January 8th.

The stock underperformed when compared to some of its competitors Thursday, as Johnson & Johnson (JNJ) fell 0.39% to $242.04, Pfizer Inc. (PFE) fell 1.61% to $26.86, and AbbVie Inc. (ABBV) fell 1.01% to $225.37.

Trading volume (2.3 M) remained 803,502 below its 50-day average volume of 3.1 M.

Data source: Dow Jones Market Data, FactSet. Data compiled March 12, 2026.

This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.

(END) Dow Jones Newswires

03-12-26 1632ET

### Related Stocks

- [ABBV.US](https://longbridge.com/en/quote/ABBV.US.md)
- [JNJ.US](https://longbridge.com/en/quote/JNJ.US.md)
- [LLY.US](https://longbridge.com/en/quote/LLY.US.md)
- [PFE.US](https://longbridge.com/en/quote/PFE.US.md)
- [BMY.US](https://longbridge.com/en/quote/BMY.US.md)
- [XLV.US](https://longbridge.com/en/quote/XLV.US.md)
- [IHE.US](https://longbridge.com/en/quote/IHE.US.md)
- [SBIO.US](https://longbridge.com/en/quote/SBIO.US.md)
- [XBI.US](https://longbridge.com/en/quote/XBI.US.md)
- [ELIL.US](https://longbridge.com/en/quote/ELIL.US.md)
- [LLYX.US](https://longbridge.com/en/quote/LLYX.US.md)
- [BBH.US](https://longbridge.com/en/quote/BBH.US.md)
- [VHT.US](https://longbridge.com/en/quote/VHT.US.md)
- [PILL.US](https://longbridge.com/en/quote/PILL.US.md)
- [IXJ.US](https://longbridge.com/en/quote/IXJ.US.md)

## Related News & Research

- [Better Buy Right Now: Johnson & Johnson Vs. Pfizer](https://longbridge.com/en/news/282434520.md)
- [BUZZ-Street View: J&J's strength in product pipeline to help navigate pricing pressure](https://longbridge.com/en/news/282829283.md)
- [Lilly to acquire CrossBridge Bio for up to $300m](https://longbridge.com/en/news/282813734.md)
- [Lilly Moves To Expand Obesity Pill Use](https://longbridge.com/en/news/283037631.md)
- [Johnson & Johnson (NYSE:JNJ) Increases Dividend to $1.34 Per Share](https://longbridge.com/en/news/282754323.md)